Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/9235
Title: beta(1)- and beta(2)-Adrenoceptor antagonist activity of a series of para-substituted N-isopropylphenoxypropanolamines.
Austin Authors: Louis, SN;Nero, Tracy L;Iakovidis, D;Colagrande, FM;Jackman, GP;Louis, WJ
Affiliation: Clinical Pharmacology and Therapeutics Unit, The University of Melbourne, Department of Medicine, Austin and Repatriation Medical Centre 3084, Victoria, Heidelberg, Australia
Issue Date: 1-Nov-1999
Publication information: European Journal of Medicinal Chemistry; 34(11): 919-937
Abstract: To further explore the structure-activity relationships of beta-adrenoceptor (beta-AR) antagonists, a series of 25 para-substituted N-isopropylphenoxy-propanolamines were synthesised, nine of which are new compounds. All have been examined for their ability to antagonise beta(1)-ARs in rat atria and beta(2)-ARs in rat trachea. Substitution in the para-position of the phenyl ring is thought to confer beta(3)-specificity and the selectivity of these compounds for the beta(1)-AR ranges from 1.5-234. None of the compounds tested were selective for the beta(2)-AR. Of the 25 compounds studied, 22 had reasonable (pA(2) > 7) potencies for the rat beta(1)-AR. Only compound 1 displayed reasonable (pA(2) > 7) potency for the rat beta(2)-AR. Twenty two compounds were used as the training set for comparative molecular field analysis (CoMFA) of antagonist potency (pA(2)) at the rat beta(1)- and beta(2)-ARs. The inclusion of a number of additional physical characteristics improved the QSAR analysis over models derived solely using the CoMFA electrostatic and steric fields. The final models predicted the beta(1)- and beta(2)-AR potency of the compounds in the training set with high accuracy (r(2) = 0.93 and 0.86 respectively). The final beta(1)-AR model predicted the beta(1)-potencies of two out of the three test compounds, not included in the training set, with residual pA(2) values < -0.14, whereas the test compounds were not as well predicted by our final beta(2)-AR model (residual pA(2) values < -0.38).
Gov't Doc #: 10889317
URI: https://ahro.austin.org.au/austinjspui/handle/1/9235
Journal: European journal of medicinal chemistry
URL: https://pubmed.ncbi.nlm.nih.gov/10889317
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

14
checked on Oct 10, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.